Clinical Trial Update: Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression [Phase 3]

View source ↗

Summary

Phase 3 trial comparing risperidone augmentation vs. bupropion ER augmentation of SSRIs in treatment-resistant depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Unipolar Depression

Drugs mentioned

• Risperdal (risperidone)
• WELLBUTRIN XL (Bupropion hydrochloride)

Snippet

Sponsor: Vanderbilt University | Conditions: Unipolar Depression | Phase 3 | Status: COMPLETED